 <h1>Zontivity Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>vorapaxar</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about vorapaxar. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Zontivity.</p><h2>In Summary</h2><p><b>Common side effects of Zontivity include:</b> hemorrhage. <b>Other side effects include:</b> anemia and gastrointestinal hemorrhage.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to vorapaxar: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Antiplatelet agents increase the risk of bleeding, including intracranial hemorrhage (ICH) and fatal bleeding. Do not use vorapaxar in patients with active pathological bleeding or a history of stroke, TIA, or ICH.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, vorapaxar (the active ingredient contained in Zontivity) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking vorapaxar:</p><p>
<i>Less common</i>
</p><ul>
<li>Bloody or black, tarry stools</li>
<li>constipation</li>
<li>pale skin</li>
<li>severe stomach pain</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Confusion</li>
<li>headache, sudden and severe</li>
<li>nausea and vomiting</li>
<li>weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of vorapaxar may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Discouragement</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of interest or pleasure</li>
<li>rashes</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to vorapaxar: oral tablet</i></p><h3>General</h3><p>Bleeding, including life-threatening and fatal bleeding, is the most commonly reported adverse reaction.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Bleeding</p>
<p><b>Common</b> (1% to 10%): Anemia, iron deficiency<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rashes, eruptions, exanthemas<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastrointestinal bleeding<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Retinopathy or retinal disorder, diplopia/oculomotor disturbances<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Intracranial bleeding<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Zontivity (vorapaxar)." Merck &amp; Company Inc, Whitehouse Station, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Zontivity (vorapaxar)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: protease-activated receptor-1 antagonists</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zontivity &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Peripheral Arterial Disease</li>
<li>Prevention of Atherothrombotic Events</li>
<li>Thromboembolic Disorder</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to vorapaxar: oral tablet</i></p><h3>General</h3><p>Bleeding, including life-threatening and fatal bleeding, is the most commonly reported adverse reaction.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Bleeding</p><p><b>Common</b> (1% to 10%): Anemia, iron deficiency<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rashes, eruptions, exanthemas<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastrointestinal bleeding<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Retinopathy or retinal disorder, diplopia/oculomotor disturbances<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Intracranial bleeding<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Zontivity (vorapaxar)." Merck &amp; Company Inc, Whitehouse Station, NJ. </p><h2>More about Zontivity (vorapaxar)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: protease-activated receptor-1 antagonists</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zontivity &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Peripheral Arterial Disease</li>
<li>Prevention of Atherothrombotic Events</li>
<li>Thromboembolic Disorder</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>